Qianjiang Yongan Pharmaceutical Co., Ltd. (SHE:002365)

SHE:002365 Revenue

Qianjiang Yongan Pharmaceutical had revenue of 235.90M CNY in the quarter ending March 31, 2026, with 37.83% growth. This brings the company's revenue in the last twelve months to 847.91M, up 4.25% year-over-year. In the year 2025, Qianjiang Yongan Pharmaceutical had annual revenue of 783.17M, down -6.63%.

• Revenue (ttm): 847.91M
• Revenue Growth: +4.25%
• P/S Ratio: 4.17
• Revenue / Employee: 929.73K
• Employees: 912
• Market Cap: 3.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	783.17M	-55.65M	-6.63%
Dec 31, 2024	838.81M	-134.08M	-13.78%
Dec 31, 2023	972.89M	-489.56M	-33.48%
Jan 1, 2023	1.46B	-102.96M	-6.58%
Jan 1, 2022	1.57B	392.56M	33.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error